AB — AB Science SA Cashflow Statement
0.000.00%
Last trade - 00:00- €65.08m
- €73.85m
- €1.17m
Annual cashflow statement for AB Science SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.5 | -13.6 | -12 | -7.83 | -1.56 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.07 | -1.03 | -2.73 | 1.64 | -0.82 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.52 | -2.83 | -4.42 | 6.05 | -1.92 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.2 | -17.5 | -16.9 | 0.525 | -4.29 |
| Capital Expenditures | -0.564 | -0.644 | -0.345 | -0.155 | -0.282 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.026 | 0.284 | -0.269 | 0.019 | 0.058 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.59 | -0.36 | -0.614 | -0.136 | -0.224 |
| Financing Cash Flow Items | — | 0.001 | -0.001 | -0.001 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.84 | 16.4 | 16.3 | 1.53 | 6.69 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -11.9 | -1.45 | -1.2 | 1.92 | 2.18 |